Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ReportLanguage
en
Metadata
Show full item recordTitle
Policy Framework for Population Screening for CancerTranslated Title
Beleidskader Bevolkingsonderzoeken naar KankerPubliekssamenvatting
Het Beleidskader Bevolkingsonderzoeken naar Kanker (BBK) geeft een overzicht van de wettelijke en beleidsmatige kaders voor de drie bevolkingsonderzoeken in Nederland naar kanker: borst-, baarmoederhals- en darmkanker. Daarnaast beschrijft het de samenwerking en onderlinge verhoudingen van partijen die betrokken zijn bij de voorbereiding, besluitvorming en uitvoering van deze bevolkingsonderzoeken. Op deze manier werken de betrokken partijen optimaal samen. Het Beleidskader is opgeteld door het RIVM en is vastgesteld door het ministerie van Volksgezondheid, Welzijn en Sport (VWS). Het document wordt regelmatig getoetst en zo nodig aangepast aan de actualiteit. <br> <br>Het RIVM ziet er als landelijke regiehouder op toe dat de bevolkingsonderzoeken voor de deelnemers een hoge kwaliteit hebben, en goed bereikbaar en betaalbaar zijn. Op die manier ontstaat een optimaal 'aanbod' voor de deelnemers aan de bevolkingsonderzoeken. Het Beleidskader is een instrument om de regie te voeren. Het vormt ook de basis voor de zogeheten uitvoeringskaders, waarin per bevolkingsonderzoek de precieze wijze waarop en door wie de bevolkingsonderzoeken worden uitgevoerd, is uitgewerkt. <br> <br>De bevolkingsonderzoeken bestaan uit een reeks van opeenvolgende handelingen die door verschillende partijen worden uitgevoerd en gecoördineerd (de uitnodiging voor het onderzoek, het onderzoek zelf, de beoordeling van de uitslag, de communicatie, en de eventuele doorverwijzing). Deze handelingen moeten goed op elkaar aansluiten en efficiënt gestructureerd zijn om de kwaliteit van het bevolkingsonderzoek te waarborgen. <br>The Policy Framework for Population Screening for Cancer provides an overview of the legal and policy frameworks for the three population screening programmes for cancer in the Netherlands, namely for breast, cervical and bowel cancer. In addition, it describes the cooperation and the various relationships between the parties who are involved in the preparation, decision-making and implementation of the population screening programmes. This optimises the way in which the parties involved can work together. The Policy Framework has been drawn up by the National Institute for Public Health and the Environment (RIVM) and formalised by the Ministry of Health, Welfare and Sport (VWS). The document is regularly checked and updated when necessary to reflect the actual situation. <br> <br>The RIVM has the nationwide coordinating role, meaning that they monitor to ensure that high-quality population screening is provided for the participants and that it is easily accessible and affordable. This creates the optimum 'offering' for those participating in population screening. The Policy Framework is a tool for coordinating the programmes. It is also part of what are known as the 'implementation frameworks' in which the exact method is described for each population screening programme, along with who performs it. <br> <br>The population screening programme consists of a sequential series of actions that are carried out and coordinated by various parties (the invitation to take part in the programme, the investigation itself, the assessment of the results, the communication of the results and any referrals that may be needed). These activities must be aligned with each other well and must be efficiently structured in order to guarantee the quality of the population screening. <br>
Sponsors
VWSCollections
Related items
Showing items related by title, author, creator and subject.
-
Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.Sen, Abhijit; Papadimitriou, Nikos; Lagiou, Pagona; Perez-Cornago, Aurora; Travis, Ruth C; Key, Timothy J; Murphy, Neil; Gunter, Marc; Freisling, Heinz; Tzoulaki, Ioanna; et al. (2018-06-26)The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 mL/day and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 mL/day versus 12 mL/day) the HRs were 1.02 (95% CI, 0.94-1.09) and 0.98 (95% CI, 0.90-1.07) for risk of total prostate cancer, and 0.97 (95% CI, 0.79-1.21) and 0.89 (95% CI, 0.70-1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages. This article is protected by copyright. All rights reserved.
-
Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Agudo, Antonio; Cayssials, Valerie; Bonet, Catalina; Tjønneland, Anne; Overvad, Kim; Boutron-Ruault, Marie-Christine; Affret, Aurélie; Fagherazzi, Guy; Katzke, Verena; Schübel, Ruth; et al. (2018-04-01)Chronic inflammation plays a critical role in the pathogenesis of the 2 major types of gastric cancer. Several foods, nutrients, and nonnutrient food components seem to be involved in the regulation of chronic inflammation.
-
Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort.Botteri, E; Ferrari, P; Roswall, N; Tjønneland, A; Hjartåker, A; Huerta, J M; Fortner, R T; Trichopoulou, A; Karakatsani, A; La Vecchia, C; et al. (2017-11-15)Findings on the association between alcohol consumption and bladder cancer are inconsistent. We investigated that association in the European Prospective Investigation into Cancer and Nutrition cohort. We included 476,160 individuals mostly aged 35-70 years, enrolled in ten countries and followed for 13.9 years on average. Hazard ratios (HR) for developing urothelial cell carcinoma (UCC; 1,802 incident cases) were calculated using Cox proportional hazards models. Alcohol consumption at baseline and over the life course was analyzed, as well as different types of beverages (beer, wine, spirits). Baseline alcohol intake was associated with a statistically nonsignificant increased risk of UCC (HR 1.03; 95% confidence interval (CI) 1.00-1.06 for each additional 12 g/day). HR in smokers was 1.04 (95% CI 1.01-1.07). Men reporting high baseline intakes of alcohol (>96 g/day) had an increased risk of UCC (HR 1.57; 95% CI 1.03-2.40) compared to those reporting moderate intakes (<6 g/day), but no dose-response relationship emerged. In men, an increased risk of aggressive forms of UCC was observed even at lower doses (>6 to 24 g/day). Average lifelong alcohol intake was not associated with the risk of UCC, however intakes of spirits > 24 g/day were associated with an increased risk of UCC in men (1.38; 95% CI 1.01-1.91) and smokers (1.39; 95% CI 1.01-1.92), compared to moderate intakes. We found no association between alcohol and UCC in women and never smokers. In conclusion, we observed some associations between alcohol and UCC in men and in smokers, possibly because of residual confounding by tobacco smoking.